Enlarged middle fossa vestibular schwannoma surgery: Experience with 735 cases

Citation
M. Gjuric et al., Enlarged middle fossa vestibular schwannoma surgery: Experience with 735 cases, OTOL NEURO, 22(2), 2001, pp. 223-230
Citations number
54
Categorie Soggetti
Otolaryngology
Journal title
OTOLOGY & NEUROTOLOGY
ISSN journal
15317129 → ACNP
Volume
22
Issue
2
Year of publication
2001
Pages
223 - 230
Database
ISI
SICI code
1531-7129(200103)22:2<223:EMFVSS>2.0.ZU;2-4
Abstract
Objective: To show the clinical outcome in patients with sporadic vestibula r schwannoma (VS) operated on by the enlarged middle cranial fossa approach (EMFA). Study Design: Retrospective case review. Setting: A tertiary referral center with four neurotologists experienced in EMFA surgery. Patients: There were 376 women and 359 men, with a mean age of 51.1 years ( range, 12-77). Intervention: Enlarged middle cranial fossa approach surgery. Main Outcome Measures: Magnetic resonance imaging and computed tomography s cans were used for follow-up and reevaluation of the operative sites. Facia l nerve function and hearing were tested. Results: Overall complete VS removal was achieved in 97.1% of patients. The re were two recurrences (0.3 %) after microscopically complete tumor remova l. Depending on the tumor size, postoperative normal and near-normal facial outcome ranged from 83% to 99% (average, 92%), and hearing at or near the preoperative level (+/- 15 dB pure-tone average or +/-: 15% speech discrimi nation) was preserved in 60.2%, 48.2%, 23.9%, and 17.6%, respectively. Conclusions: The EMFA is an excellent low-morbidity approach for VS removal with limited cerebellopontine angle extension (2 cm). Specific advantages of the EMFA are the superior internal auditory canal exposure, resulting in an extremely low tumor recurrence rate; best capability for hearing preser vation; and minimal incidence of cerebrospinal fluid leaks. Postoperative f acial function outcome compares with that of other surgical approaches. The best results are achieved in subjects with small tumors and good hearing, advocating early diagnosis and treatment.